Uncategorized
NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, announces the appointment of Lewis J. Stuart as Chief Commercial Officer. Mr. Stuart joined NovaBay on December 1 and brings more than 30 years of biopharmaceutical industry experience. At NovaBay, he will be responsible for leading all commercial activities, including dri